164 related articles for article (PubMed ID: 33037645)
21. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
Blom J; Törnberg S
J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
[TBL] [Abstract][Full Text] [Related]
22. The Impact of a Six-Year Existing Screening Programme Using the Faecal Immunochemical Test in Flanders (Belgium) on Colorectal Cancer Incidence, Mortality and Survival: A Population-Based Study.
Tran TN; Hoeck S; De Schutter H; Janssens S; Peeters M; Van Hal G
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674409
[TBL] [Abstract][Full Text] [Related]
23. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme.
Gill MD; Bramble MG; Rees CJ; Lee TJ; Bradburn DM; Mills SJ
Br J Cancer; 2012 Jul; 107(3):417-21. PubMed ID: 22782347
[TBL] [Abstract][Full Text] [Related]
24. Older age, symptoms, or anemia: Which factors increase colorectal cancer risk with a positive fecal immunochemical test?
Hamarneh Z; Symonds EL; Kholmurodova F; Cock C
J Gastroenterol Hepatol; 2020 Jun; 35(6):1002-1008. PubMed ID: 31606908
[TBL] [Abstract][Full Text] [Related]
25. The detection of interval colorectal cancers following screening by fecal immunochemical test may predict worse outcomes and prompt ethical concerns: a 6-year population-based cohort study in a full district.
Asteria CR; Lucchini G; Guarda L; Ricci P; Pagani M; Boccia L
Eur J Cancer Prev; 2019 Jan; 28(1):17-26. PubMed ID: 29111981
[TBL] [Abstract][Full Text] [Related]
26. Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.
Parente F; Vailati C; Boemo C; Bonoldi E; Ardizzoia A; Ilardo A; Tortorella F; Cereda D; Cremaschini M; Moretti R
Dig Liver Dis; 2015 Jan; 47(1):68-72. PubMed ID: 25306524
[TBL] [Abstract][Full Text] [Related]
27. Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy.
Giorgi Rossi P; Carretta E; Mangone L; Baracco S; Serraino D; Zorzi M;
J Med Screen; 2018 Mar; 25(1):32-39. PubMed ID: 28195508
[TBL] [Abstract][Full Text] [Related]
28. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
29. Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the "interval cancer" perspective.
Tran TN; Peeters M; Hoeck S; Van Hal G; Janssens S; De Schutter H
Br J Cancer; 2022 Apr; 126(7):1091-1099. PubMed ID: 35022524
[TBL] [Abstract][Full Text] [Related]
30. One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).
Wong G; Hope RL; Howard K; Chapman JR; Castells A; Roger SD; Bourke MJ; Macaskill P; Turner R; Williams G; Lim WH; Lok CE; Diekmann F; Cross NB; Sen S; Allen RDM; Chadban SJ; Pollock CA; Tong A; Teixeira-Pinto A; Yang JYH; Williams N; Au EHK; Kieu A; James L; Craig JC
J Am Soc Nephrol; 2019 Jun; 30(6):1061-1072. PubMed ID: 31040191
[TBL] [Abstract][Full Text] [Related]
31. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
32. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancers detected through screening are associated with lower stages and improved survival.
Lindebjerg J; Osler M; Bisgaard C
Dan Med J; 2014 Jan; 61(1):A4758. PubMed ID: 24393588
[TBL] [Abstract][Full Text] [Related]
35. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
[TBL] [Abstract][Full Text] [Related]
36. Colon capsule endoscopy versus CT colonography in FIT-positive colorectal cancer screening subjects: a prospective randomised trial-the VICOCA study.
González-Suárez B; Pagés M; Araujo IK; Romero C; Rodríguez de Miguel C; Ayuso JR; Pozo À; Vila-Casadesús M; Serradesanferm A; Ginès À; Fernández-Esparrach G; Pellisé M; López-Cerón M; Flores D; Córdova H; Sendino O; Grau J; Llach J; Serra-Burriel M; Cárdenas A; Balaguer F; Castells A
BMC Med; 2020 Sep; 18(1):255. PubMed ID: 32943059
[TBL] [Abstract][Full Text] [Related]
37. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.
Steele RJ; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser CG
Gut; 2012 Apr; 61(4):576-81. PubMed ID: 21930729
[TBL] [Abstract][Full Text] [Related]
38. Screen-detected and interval colorectal cancers in England: Associations with lifestyle and other factors in women in a large UK prospective cohort.
Blanks R; Burón Pust A; Alison R; He E; Barnes I; Patnick J; Reeves GK; Floud S; Beral V; Green J
Int J Cancer; 2019 Aug; 145(3):728-734. PubMed ID: 30694563
[TBL] [Abstract][Full Text] [Related]
39. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test.
Pin-Vieito N; Iglesias MJ; Remedios D; Rodríguez-Alonso L; Rodriguez-Moranta F; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Martínez-Bauer E; Campo R; Bujanda L; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Cubiella J; On Behalf Of The Colonpredict Study Investigators
World J Gastroenterol; 2020 Jan; 26(1):70-85. PubMed ID: 31933515
[TBL] [Abstract][Full Text] [Related]
40. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]